A Phase 1 Dose Escalation and Cohort Expansion Study of the Safety and Efficacy of Anti-CD19 AllogeneicCRISPR-Cas9???Engineered T Cells (CTX110) in Subjects With Relapsed or Refractory B Cell Malignancies

Project: Research project

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.

Medicine & Life Sciences